Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle B Woodward

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Organ Transplantation|December 3, 2015
Novel technologies to engineer graft for tolerance inductionKyle B Woodward, Feng Wang, Hong Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 10, 2011
Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in miceEsma S Yolcu, Hong Zhao, Laura Bandura-Morgan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2019
Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilegeKyle B Woodward, Hong Zhao, Pradeep Shrestha, et al.
Biomaterials|November 21, 2018
Localized immune tolerance from FasL-functionalized PLG scaffoldsMichael Skoumal, Kyle B Woodward, Hong Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2020
Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic ImmunosuppressionLalit Batra, Pradeep Shrestha, Hong Zhao, et al.
Journal for Immunotherapy of Cancer|January 2, 2024
Discovery of U2AF1 neoantigens in myeloid neoplasmsMelinda Ann Biernacki, Jessica Lok, Ralph Graeme Black, et al.
Nature Materials|June 6, 2018
Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptanceDevon M Headen, Kyle B Woodward, María M Coronel, et al.
The Journal of Clinical Investigation|August 25, 2020
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemiaMelinda A Biernacki, Kimberly A Foster, Kyle B Woodward, et al.
Blood|April 29, 2024
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F Krakow, Michelle Brault, Corinne Summers, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Organ Transplantation|December 3, 2015
Novel technologies to engineer graft for tolerance inductionKyle B Woodward, Feng Wang, Hong Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 10, 2011
Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in miceEsma S Yolcu, Hong Zhao, Laura Bandura-Morgan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2019
Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilegeKyle B Woodward, Hong Zhao, Pradeep Shrestha, et al.
Biomaterials|November 21, 2018
Localized immune tolerance from FasL-functionalized PLG scaffoldsMichael Skoumal, Kyle B Woodward, Hong Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2020
Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic ImmunosuppressionLalit Batra, Pradeep Shrestha, Hong Zhao, et al.
Journal for Immunotherapy of Cancer|January 2, 2024
Discovery of U2AF1 neoantigens in myeloid neoplasmsMelinda Ann Biernacki, Jessica Lok, Ralph Graeme Black, et al.
Nature Materials|June 6, 2018
Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptanceDevon M Headen, Kyle B Woodward, María M Coronel, et al.
The Journal of Clinical Investigation|August 25, 2020
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemiaMelinda A Biernacki, Kimberly A Foster, Kyle B Woodward, et al.
Blood|April 29, 2024
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F Krakow, Michelle Brault, Corinne Summers, et al.
Pageof 1